Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

Labour Minister and Economic Development Deputy Minister Dr. Anil Jayantha Fernando yesterday declared that Sri Lanka is ...

Analyst highlights biotech stocks driving innovation in respiratory, genetic and neurological disease treatments.

Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., today announced the appointment of ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $6.36, moving 6.33% from the previous trading session.

(Alliance News) - Allergy Therapeutics PLC said on Thursday that the trial of its short-course peanut allergy vaccine candidate VLP Peanut has had "positive progress" in phase 1 and phase 2a. The ...

Normally, Tau proteins stabilize microtubules and support neuronal function, but in neurodegenerative diseases such as ...

City has unveiled numerous initiatives and action plans to promote green growth, focusing on renewable energy, the circular ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...

The 2022 Option Agreement between Astellas and Taysha has expiredRegaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus ...